Clin2
NCT04623099Possibly a fitRecruiting

Personalized escitalopram dosing for anxious teens

Anxiety

Treatments studied

Part of Mental health clinical trials.

This study tests whether a genetics-guided approach to choosing and adjusting escitalopram (an anxiety medicine) can improve safety and effectiveness for anxious teens. It also checks that participants have certain anxiety severity scores and can safely take the study medication.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
132 people
Ages
12 years to 17 years
Study type
Interventional

Who can take part

  • You are 12 to 17 years old, and a parent/guardian can join consent and safety monitoring.
  • You have anxiety that fits specific diagnoses (generalized, social, and/or separation anxiety), confirmed by a structured interview.
  • Your anxiety symptom scores are high enough at two study visits (PARS) and your overall severity is high enough (CGI-S).
  • No major start or changes to psychotherapy within the last 8 weeks, and any current therapy must have been stable for at least 2 months.
  • You can attend follow-up visits at least from within about 90 minutes of the university and have no concerning suicide risk at screening.
  • You can safely take the medication (normal exam/EKG for QTc, not pregnant, negative drug test, no escitalopram allergy, and you can swallow capsules).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04245436Recruiting· Phase 4
Testing antidepressants for teens with anxiety

This trial studies whether an antidepressant can help teens (ages 12–17) with anxiety disorders such as generalized, social, separation, or panic anxiety. It looks at both early and longer-term success of treatment, while monitoring safety closely with a caregiver.

Cincinnati, Ohio
NCT06081348Recruiting· Phase 2
Sertraline vs. placebo for anxiety in kids with developmental disorders

This trial compares sertraline (a common antidepressant) to a placebo (a pill with no medicine) to see which better reduces anxiety in children and teens who also have a neurodevelopmental disorder like autism, ADHD, or Tourette's. The goal is to help you and your child understand if this treatment might offer relief from anxiety.

Calgary, Alberta
NCT04245748Recruiting· Phase 4
Finding the best order of treatments for anxious depression

This study tests which treatment sequence works best for people with anxiety conditions (generalized, social, separation) and/or panic, who also have significant depression/anxiety symptoms. It may help you find a more effective step-by-step plan and compare treatment orders.

Cincinnati, Ohio
NCT04221997Recruiting· Phase 4
Sertraline study for anxious children and teens

This trial tests whether sertraline (an anti-anxiety medicine) helps children and teens with generalized, separation, and/or social anxiety disorders. It also includes healthy children/teens for comparison so researchers can better understand safety and symptoms over time.

Cincinnati, Ohio
NCT06826326Enrolling by invitation· Phase 2
Brain imaging of an antidepressant in teens with autism

This study tests if the antidepressant escitalopram can improve brain function in teenagers with autism. Participants will take the medicine and have brain scans (MRI) to see how it affects brain activity.

Kansas City, Kansas
NCT06853587Recruiting
Genetic test to help pick antidepressant for teens

This study tests whether using a cheek swab DNA test can help choose a better antidepressant for teenagers with anxiety or depression. The goal is to see if this personalized approach leads to fewer side effects and better results.

Calgary, Alberta

Hear when a new Anxiety trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.